AIM
AUPH icon

Aigen Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Aigen Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,671
Closed -$90.4K – 788
2025
Q2 		$90.4K Buy
+10,671
New +$85.5K 0.01% 726
2023
Q3 		– Sell
-29,675
Closed -$287K – 819
2023
Q2 		$287K Buy
+29,675
New +$308K 0.04% 509
2022
Q2 		– Sell
-10,080
Closed -$125K – 525
2022
Q1 		$125K Buy
+10,080
New +$156K 0.02% 487
2020
Q2 		– Sell
-13,379
Closed -$194K – 828
2020
Q1 		$194K Buy
+13,379
New +$236K 0.03% 717

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aigen Investment Management's AUPH Position: Q3 2025 in Review

Aigen Investment Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2025, closing a stake of 10,671 shares — an estimated $90.4K sold.

Aigen Investment Management first reported a position in AUPH in Q1 2020 and held it in 4 quarters. The position peaked at $287K in Q2 2023. 242 funds tracked by Wall St. Rank hold AUPH as of Q3 2025.

  • Aigen Investment Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Aigen Investment Management sold 10,671 Aurinia Pharmaceuticals shares in Q3 2025, an estimated $90.4K.
  • Aigen Investment Management first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Aigen Investment Management's Aurinia Pharmaceuticals position peaked at $287K in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.